Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers

Table 3

Assay of p53 antibody, CEA, and CA19-9.

	Pancreatic cancer		Biliary tract cancer		Pancreatobiliary cancer
	Mean ± SD^*1	CV^*2	Mean ± SD^*1	CV^*2	Mean ± SD^*1	CV^*2
p53 antibody (U/mL)	0.716 ± 0.30	0.42	0.716 ± 0.42	0.59	0.716 ± 0.31	0.44
CEA (ng/mL)	38.33 ± 146.8	3.83	21.42 ± 25.0	1.16	34.01 ± 127.05	3.73
CA19-9 (U/L)	3142.9 ± 9146.8	2.91	5859.8 ± 16446.5	2.79	3836.6 ± 11311.7	2.94

∗1SD: standard deviation.
∗2CV: coefficient of variation.